Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    17251666 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated A Prospective, Open, Non-randomized Phase I/II Study of Therapeutic Angiogenesis in Diabetic Patients With Critic Ischemia of Lower Limbs While Administering Positive CD133 Mobilized With G-CSF
Condition: Diabetic Patients With Critic Ischemia in Lower Limbs Who Are Administered With CD133+ Cells Mobilized by G-CSF
Intervention: Biological: CD133+ cells transplant
2 Unknown  TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation
Conditions: Buerger Disease;   Arteriosclerosis Obliterans
Intervention: Procedure: Autologous Bone Marrow Mononuclear Cell Implantation

Indicates status has not been verified in more than two years